Rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: long-term follow-up of a phase 2 study from the German Hodgkin Study Group.
Dennis A EichenauerAnnette PlütschowMichael FuchsSylvia HartmannMartin-Leo HansmannBoris BöllBastian von TresckowPeter BorchmannAndreas EngertPublished in: Leukemia (2019)